A 52-year-old woman with FIGO 2018 Stage IIIB cervical cancer (tumor extending to pelvic wall, no distant metastasis) completes concurrent chemoradiation. Follow-up PET-CT at 3 months shows complete metabolic response. What is the recommended surveillance strategy?

• A Clinical examination and cytology every 3 months for 2 years, then every 6 months up to 5 years ✓
• B PET-CT every 3 months for 2 years
• C Routine HPV testing every 6 months
• D MRI pelvis annually for 5 years

Explanation

Standard surveillance after chemoradiation for cervical cancer includes clinical history, physical examination, and cervical/vaginal cytology every 3 months for 2 years, then every 6 months for years 3 to 5, followed by annually. Routine PET-CT or MRI is not recommended for asymptomatic surveillance. HPV testing is not part of post-treatment surveillance guidelines.

Reference: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer, 2024 ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.